Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (91-100 of 460) with videos related to

Pageof 46
Sort By:
Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept studyArchana Thakur, John Scholler, Dana L Schalk, et al.
Nature Medicine|April 20, 2022
Engineered cellular immunotherapies in cancer and beyondAmanda V Finck, Tatiana Blanchard, Christopher P Roselle, et al.
Current Opinion in Immunology|November 19, 2021
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapyNils Wellhausen, Sangya Agarwal, Philipp C Rommel, et al.
The New England Journal of Medicine|August 12, 2011
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemiaDavid L Porter, Bruce L Levine, Michael Kalos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 InhibitionJiangtao Ren, Xiaojun Liu, Chongyun Fang, et al.
Gene Therapy|June 9, 2018
Driving cars to the clinic for solid tumorsMauro Castellarin, Keisuke Watanabe, Carl H June, et al.
Cancer Discovery|April 13, 2022
Next-Generation CAR T-cell TherapiesRegina M Young, Nils W Engel, Ugur Uslu, et al.
Cytotherapy|June 21, 2025
The next innovations in chimeric antigen receptor T cell immunotherapies for cancerKusala Anupindi, Julia Malachowski, Isabella Hodson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Engineering a Juxtamembrane-Targeting CAR T-Cell Against Mesothelin: A Novel Binder Resilient to Shed Antigen in Ovarian and Pancreatic CancerJohn Scholler, Ai Song, Mansi Deshmukh, et al.
Pageof 46

Showing results (91-100 of 460) with videos related to

Sort By:
Pageof 46
Blood|March 1, 2014
Antibody-modified T cells: CARs take the front seat for hematologic malignanciesMarcela V Maus, Stephan A Grupp, David L Porter, et al.
Journal of Cancer Research and Clinical Oncology|May 26, 2020
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept studyArchana Thakur, John Scholler, Dana L Schalk, et al.
Nature Medicine|April 20, 2022
Engineered cellular immunotherapies in cancer and beyondAmanda V Finck, Tatiana Blanchard, Christopher P Roselle, et al.
Current Opinion in Immunology|November 19, 2021
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapyNils Wellhausen, Sangya Agarwal, Philipp C Rommel, et al.
The New England Journal of Medicine|August 12, 2011
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemiaDavid L Porter, Bruce L Levine, Michael Kalos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 InhibitionJiangtao Ren, Xiaojun Liu, Chongyun Fang, et al.
Gene Therapy|June 9, 2018
Driving cars to the clinic for solid tumorsMauro Castellarin, Keisuke Watanabe, Carl H June, et al.
Cancer Discovery|April 13, 2022
Next-Generation CAR T-cell TherapiesRegina M Young, Nils W Engel, Ugur Uslu, et al.
Cytotherapy|June 21, 2025
The next innovations in chimeric antigen receptor T cell immunotherapies for cancerKusala Anupindi, Julia Malachowski, Isabella Hodson, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Engineering a Juxtamembrane-Targeting CAR T-Cell Against Mesothelin: A Novel Binder Resilient to Shed Antigen in Ovarian and Pancreatic CancerJohn Scholler, Ai Song, Mansi Deshmukh, et al.
Pageof 46